FRISCO, Texas, July 26 /PRNewswire/ -- OxySure(TM) Systems, Inc., a leading developer and manufacturer of next-generation emergency oxygen solutions, announced today that Vincent N. Mosesso, Jr., M.D., FACEP, has been named to the company’s Advisory Board. Dr. Mosesso is nationally respected throughout the field of emergency medicine for his leadership skills, clinical expertise and contributions to emergency and pre-hospital care, including the role of police and first responders in the treatment of out-of-hospital cardiac arrests.
(Logo: http://www.newscom.com/cgi-bin/prnh/20051215/OXYSURELOGO )
Dr. Mosesso is Medical Director for Pre-hospital Care at the University of Pittsburgh Medical Center (UPMC) and he serves as Associate Professor of Emergency Medicine at the University of Pittsburgh School of Medicine. He also serves as Medical Director and on the Board of the Sudden Cardiac Arrest Association, a successor organization to the National Center for Early Defibrillation, which he founded. In addition, Dr. Mosesso is the assistant medical director of the City of Pittsburgh Emergency Medical Services and a medical command physician for Delta Airlines through the Center for Emergency Medicine of Western Pennsylvania. Dr. Mosesso is a Fellow of the American College of Emergency Physicians (FACEP) and is a member the Society for Academic Emergency Medicine, the American Heart Association and the National Association of Emergency Medical Services Physicians. In 1998, he was named “Physician of the Year” by the Pennsylvania Emergency Health Services Council and he has authored or co-authored more than 40 peer-reviewed scientific manuscripts and textbook chapters related to emergency medicine.
“The addition of Dr. Mosesso to our Advisory Board is continuing evidence of our commitment to clinical and product excellence”, said Julian Ross, Chairman & CEO of OxySure(TM). “We see a tremendous opportunity to combine Dr. Mosesso’s clinical experience with our expertise in research and development to continue to make medical oxygen safer and more accessible to consumers in cardiovascular, respiratory or general medical emergencies.”
“I agreed to join the OxySure(TM) Advisory Board because I am excited about the potential benefits of this innovative method for making medical oxygen available in emergency situations,” said Dr. Mosesso. “The device can be used easily and safely by laypersons with minimal training, thereby allowing oxygen to be provided to persons with respiratory distress before emergency care professionals can respond.”
About OxySure(TM)
OxySure(TM) Systems, Inc. is a Frisco, Texas-based medical technology company focused on the design, manufacture and distribution of specialty medical and respiratory products. The company has developed a third generation catalytic process and methodology to generate medically pure (USP) oxygen from two proprietary inert powders. The company has developed numerous worldwide patents on this technology, which makes the provision of medical oxygen safer, lighter and less expensive than traditional oxygen provision systems. OxySure’s easy to use products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in two multi-billion dollar markets involving both established and expansion customer markets: (1) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (2) those requiring immediate protection and escape from exposure situations or oxygen- deficient situations in industrial, mining, military, or other public settings. http://www.OxySure.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20051215/OXYSURELOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comOxySure Systems, Inc.
CONTACT: media, Jon Staples of OxySure Systems, Inc., +1-214-618-7923, orjstaples@oxysure.com
Web site: http://www.oxysure.com/
